Sarcopenia Treatment Industry Outlook 2025-2029: Market Set to Cross $4.72 Billion Milestone

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts

How Large Will the Sarcopenia Treatment Market Size By 2025?
The market for sarcopenia treatment has seen robust growth in recent years. It is projected to grow from $3.52 billion in 2024 to $3.73 billion in 2025, at a compound annual growth rate (CAGR) of 6.1%. This expansion during the historical period is tied to factors such as an aging population, increased awareness and diagnosis, changes in lifestyle, public health initiatives, and regulatory approvals.

How Big Is the Sarcopenia Treatment Market Size Expected to Grow by 2029?
The market for treating sarcopenia is projected to experience significant growth in the coming years, reaching a value of $4.72 billion by 2029, with a compound annual growth rate (CAGR) of 6.0%. This surge during the forecast period can be linked to factors such as personalized medicine, nutritional interventions, the use of digital health platforms, the education and empowerment of patients, and worldwide health drives. Top trends to look out for during this period include customization of therapies, advent of new drug categories, incorporation of digital health, joint research efforts, and research and development.

View the full report here:
https://www.thebusinessresearchcompany.com/report/sarcopenia-treatment-global-market-report

Which Key Market Drivers Powering Sarcopenia Treatment Market Expansion and Growth?
The surge in malnutrition cases is projected to fuel the expansion of the sarcopenia treatment market in the future. Malnutrition encompasses deficiencies, overconsumption or the improper balance of energy and nutrients in an individual's diet, including undernourishment, obesity, and diseases related to poor dietary habits. The aim of sarcopenia treatments is to alleviate malnutrition and sarcopenia's coexistent conditions in the elderly by offering interventions such as dietary therapy and physical activities. These measures aim to enhance muscle mass, strength, and overall nutritional status. For example, the World Health Organization (WHO), a United Nations (UN) organization based in Switzerland, stated in a report published in December 2023 that malnutrition continues to pose a substantial global health issue. As of 2022, the report estimated that 462 million people were underweight and that stunting affected 149 million children under 5. The escalating prevalence of malnutrition serves as a key driver for the expansion of the sarcopenia treatment market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13926&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Sarcopenia Treatment Market?
Key market players in the sarcopenia treatment sphere are shifting their attention towards the formulation of various advanced clinical study options to provide more effective treatment choices. Clinical studies involve methodical research conducted on human subjects to assess the safety, effectiveness, and/or impact of a particular medical treatment. For example, in September 2023, Biophytis, a biotech firm based in France, received approval from the Food and Drug Administration (FDA) to commence the SARA-31 Phase 3 investigation on sarcopenia. The purpose of the study is to evaluate the safety and effectiveness of Sarconeos (BIO101) in curing sarcopenic patients who are at risk of motor disability. This study underscores a significant progress in the technology and pharmaceutical treatment methods, presenting potential safety and effectiveness benefits for patients suffering from severe sarcopenia. This is the inaugural phase 3 study on sarcopenia that has received FDA authorization. The study is expected to comprise around 900 sarcopenic patients aged 65 and above, with low walking speed and diminished hand grip strength. The primary focus will be on determining the risk of major mobility disability (MMD), walking speed, hand grip strength, and the quality of life as reported by the patients.

What Are the Emerging Segments in the Sarcopenia Treatment Market?
The sarcopenia treatment market covered in this report is segmented -

1) By Treatment Type: Protein Supplements, Vitamin B12 Supplements, Vitamin D And Calcium Supplements, Other Treatment Types
2) By Type: Primary Sarcopenia, Secondary Sarcopenia
3) By Route Of Administration: Oral, Parenteral, Enteral
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels

Subsegments:
1) By Protein Supplements: Whey Protein, Casein Protein, Soy Protein, Plant-Based Protein
2) By Vitamin B12 Supplements: Cyanocobalamin, Methylcobalamin
3) By Vitamin D And Calcium Supplements: Vitamin D2, Vitamin D3, Calcium Carbonate, Calcium Citrate
4) By Other Treatment Types: Exercise Programs, Hormone Replacement Therapy, Other Nutritional Interventions

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=13926&type=smp

Who Are the Global Leaders in the Sarcopenia Treatment Market?
Major companies operating in the sarcopenia treatment market report are Pfizer Inc., F-Hoffmann La-Roche, Merck Sharp & Dohme Corp. (Merck & Co.), AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Abbott Laboratories Inc., GlaxoSmithKline plc, Eli Lilly and Company, BASF SE, Nestle Health Science, Haleon Group of Companies, Regeneron Pharmaceuticals Inc., DSM, American Way (Amway) Corporation, Perrigo Company PLC, Intas Pharmaceuticals Ltd, Zydus Lifesciences, Fermenta Biotech Limited, Metagenics LLC, Ion Labs Inc., Makers Nutrition LLC, NutraScience Labs, AstaReal AB, NutraPak USA, BioThrive Sciences, Wellona Pharma, Healing Pharma India Pvt. Ltd., Nutrafill

Which are the Top Profitable Regional Markets for the Sarcopenia Treatment Industry?
North America was the largest region in the sarcopenia treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sarcopenia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13926

"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.